CN |
Novel somatic technology for MDMC-directed repair of autologous cells and tissue structures

MDMCTechnical adaptation areas:

●Ischemic heart and cerebrovascular diseases: such as myocardial infarction, cerebral infarction, etc.

Atherosclerotic Ischemic Damage Disease(Most degenerative diseases).

Degenerative diseases of the nervous system: such as lateral sclerosis (ALS), multiple sclerosis, multiple System atrophy, Parkinson's disease, cerebellar atrophy, senile dementia, etc.

MDMCTreatment effect analysis:

Powerful anti-inflammatory effect and clean up damaged tissue.

Powerful transitions During the period of growth function, wake up damaged cells and tissues.

Convert to new , with the function of new budding cells.

The new cells come with Normal growth of the human body.

5~10 Substantially stable.

autologous protein solution(Autologous Proteins Solution, APS) therapy extracts high concentrations from the patient's own blood high-quality proteins (anti-inflammatory cytokines) that can inhibit inflammation and metabolic growth factors that protect cartilage, inject high-quality protein-rich APS into diseased joints, and regulate protein balance to inhibit inflammation and relieve pain , to inhibit cartilage degeneration and treat damage. APS treatment technology has been certified by the European CE mark and has been listed in Europe, America and Japan, fills theThe medical gap in "suppressing degenerative arthritis pain and inflammation and promoting cartilage health".

BMJ Case Reports (the largest repository of case reports in the world)andStem Cell Translational Medicine Clinical data show that  MSC group has better therapeutic effect In the acid control group, the pain and knee function were significantly improved, and the results showed that the higher the dose of MSC, the better the effect.

Extracorporeal shock waves act on multiple interfaces between soft tissue and bone, resulting in the reflection and absorption of shock wave energy. Absorption is the primary cause of shockwave-induced osteogenic and angiogenic effects.

Phone: 400-099-1215

Company address: Tide Valley Biomedical Industrial Park, Xinxing Park, Gu'an County, Langfang City, Hebei Province

Enterprise Email: boya@newcby.com

New Century Elite Life Technology (Hebei) Co., Ltd. Copyright(C)2021 Ji ICP preparation ******* No.-1